A Secret Weapon For conolidine
Andy Chevigné and his group, RTI-5152-12 is postulated to boost the amounts of opioid peptides that bind to classical opioid receptors in the brain, causing heightened painkilling action. The LIH-RTI investigate teams established a collaboration arrangement and submitted a joint patent software in December 2020.Scientific American is part of Sprin